Patents Assigned to NED Biosystems, Inc.
  • Cancer therapy
    Patent number: 11083740
    Abstract: The present invention is directed to compositions and methods for the treatment of cancers, particularly cancers of epithelial origin. Therapy with a plurality of nutraceutical, non-chemotherapeutic and chemotherapeutic agents, that together target a plurality of cancer-supportive processes in a patient are disclosed. Among other things, the present invention encompasses the insight that redundant targeting of multiple such pathways provides effective treatment of various cancer, including late-stage cancers, metastasized cancers, and/or cancers that have failed treatment with traditional chemotherapy and/or other therapeutic modalities.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: August 10, 2021
    Assignee: NED Biosystems, Inc.
    Inventor: Rebecca Lambert Bent
  • Cancer therapy
    Patent number: 10195219
    Abstract: The present invention is directed to compositions and methods for the treatment of cancers, particularly cancers of epithelial origin. Therapy with a plurality of nutraceutical, non-chemotherapeutic and chemotherapeutic agents, that together target a plurality of cancer-supportive processes in a patient are disclosed. Among other things, the present invention encompasses the insight that redundant targeting of multiple such pathways provides effective treatment of various cancer, including late-stage cancers, metastasized cancers, and/or cancers that have failed treatment with traditional chemotherapy and/or other therapeutic modalities.
    Type: Grant
    Filed: April 11, 2014
    Date of Patent: February 5, 2019
    Assignee: NED Biosystems, Inc.
    Inventor: Rebecca Lambert Bent